Skip to main content
SpringerLink
Log in

Triiodothyronine predominant Graves’ disease in a South-East Asian population: Prevalence and clinical significance

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wenzel K.W., Lente J.R. Syndrome of persisting thyroid stimulating immunoglobulins and the growth promotion of goitre combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves’ disease. J. Endocrinol. Invest. 1983, 6: 389–394.

    CAS  PubMed  Google Scholar 

  2. Takamatsu J., Sugawara M., Kuma K., Kobayashi A., Matsuzuka F., Mozai T., Hershman J. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves’ disease. Ann. Intern. Med. 1984, 100: 372–375.

    Article  CAS  PubMed  Google Scholar 

  3. Hegedus L., Hansen J.M., Bech K., Kampmann J.P., Jensen K., Andersen E., Hansen P., Karstrup S., Bliddal H. Thyroid simulating immunoglobulins in Graves’ disease with goitre growth, low thyroxine and increasing triiodothyronine during PTU treatment. Acta Endocrinol. 1984, 107: 482–488.

    CAS  PubMed  Google Scholar 

  4. Chen J.J.S., Ladenson P.W. Discordant hypothyroxinaemia and hypertriiodothyroninaemia in treated patients with hyperthyroid Graves’ disease. J. Clin. Endocrinol. Metab. 1986, 63: 102–106.

    Article  CAS  PubMed  Google Scholar 

  5. Beech S.G., Walker S.W., Arthur J.R., Lee D., Beckett G.J. Differential control of type-1 iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes. J. Mol. Endocrinology 1995, 14: 171–177.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thyroid Unit Department of Endocrinology, Singapore General Hospital, Singapore

    A. M. L. Yong, E. S. Tai, P. H. K. Eng, S. C. Ho & D. H. C. Khoo

  2. Medical Oncology, National Cancer Centre, Singapore

    Z. W. Wong

Authors
  1. A. M. L. Yong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. S. Tai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. W. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. H. K. Eng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. C. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. H. C. Khoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yong, A.M.L., Tai, E.S., Wong, Z.W. et al. Triiodothyronine predominant Graves’ disease in a South-East Asian population: Prevalence and clinical significance. J Endocrinol Invest 24, 204–205 (2001). https://doi.org/10.1007/BF03343845

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343845

Keywords

Search

Navigation